Dede Willams

Mitsubishi Sues in China Over Red Phosphors Patent

Evocatal Takes Majority of Aevotis

LyondellBasell Upgrades Three Executives’ Positions

Pfizer to Pay $400 million to Avert Class Action Trial

DuPont Plans Fresh Share Buyback

UK Parliament Rejects Calls to Restore Fracking Halt

New Rare Earth Element Discovered in Peru

Versalis to Temporarily Restart Porto Marghera Cracker

Fired Sanofi CEO to Receive $4.4 Million Severance Pay

Clariant to Establish Strategic Alliance with Beraca

EFSA Says BPA Not an Endocrine Disruptor

Cancer Researcher Says Fracking Chemicals Are Carcinogens

BASF to Expand Global PVP Output

GSK Chief Sees More Unit IPOs as Options

Call-off of Qatari Olefins Project Could Help MEG Market

Wintershall Says Shale Debate Still Blocks Conventional Gas

Topics • Strategy

How now, Jim Ratcliffe?

US EPA Set to Restrict Certain Dyes, Phthalates and SCCPs

Technip to Acquire Zimmer from Air Liquide

Nexam and BASF End Exclusivity Pact for Crosslinkers

Latin American Chemical Distributor to be Acquired by Advent

Germany's Merck Plans to Expand in Consumer Health

Goldman, BASF, HSBC Sued Over Metals Price Fixing

Vencorex "Significantly Expanding" IPDI Capacity

Germany's Merck Commissions Biomass Power Plant in Goa

Canada's Ontario Province to Cut Neonicotinoid Use by 80%

Ineos Seeks Leaders for Move Into Offshore Exploration

Germany to Introduce Quotas for Women on Supervisory Boards

AkzoNobel to Explore Use of Waste as Feedstock

Shell Offers $90 Million to end California Litigation

Orica to Sell Chemicals Business to Blackstone for $652 million

EU Minister Warns of Course Change on US Trade Talks

Valeant Slashes Stake in Allergan After Losing Bid

Dow and Third Point Reach Agreement on Board

BASF to Sell Omega-3 Production Plant to Marine Ingredients

684 more articles

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.